Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Pomen zgodnje limfadenektomije pri bolnikih z melanomom
Avtorji:ID Hočevar, Marko (Avtor)
ID Pilko, Gašper (Avtor)
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (285,73 KB)
MD5: 10CC19E9D0BF3BEDF902B78F49B77AE9
 
Jezik:Slovenski jezik
Tipologija:1.04 - Strokovni članek
Organizacija:Logo OI - Onkološki inštitut Ljubljana
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2009
Št. strani:str. 19-21
Številčenje:Letn. 13, št. 1
PID:20.500.12556/DiRROS-8813 Novo okno
UDK:616.5-006
ISSN pri članku:1408-1741
URN:URN:NBN:SI:doc-G5Q09BZ2
COBISS.SI-ID:25692377 Novo okno
Avtorske pravice:by Authors
Opomba:BSDOCID145209;
Datum objave v DiRROS:31.08.2018
Število ogledov:3443
Število prenosov:870
Metapodatki:XML DC-XML DC-RDF
:
HOČEVAR, Marko in PILKO, Gašper, 2009, Pomen zgodnje limfadenektomije pri bolnikih z melanomom. Onkologija [na spletu]. 2009. Vol. 13, no. 1, p. 19–21. [Dostopano 17 april 2025]. Pridobljeno s: https://dirros.openscience.si/IzpisGradiva.php?lang=slv&id=8813
Kopiraj citat
  
Objavi na:Bookmark and Share


Iščem podobna dela...Prosim, počakajte...
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Onkologija
Skrajšan naslov:Onkologija
Založnik:Onkološki inštitut
ISSN:1408-1741
COBISS.SI-ID:65324032 Novo okno

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:31.08.2018

Sekundarni jezik

Jezik:Angleški jezik
Naslov:Early Lymphadenectomy in Melanoma Patients and Their Prognosis
Povzetek:Lymph node metastases are the most important prognostic factor in the patients with cutaneous melanoma and they are treated with radical lymphadenectomy. In the last 15 years, sentinel lymph node biopsy (SLNB) became the method of choice in staging regional lymph nodes in melanoma patients. The procedure provides the most accurate prognostic information and facilitates early lymphadenectomy in the patients with clinically occult regional metastases, however, therapeutic value of SLNB followed by completion lymph node dissection (CLND) in melanoma patients has not been proved. The reason might be prognostic heterogeneity of patients with positive sentinel lymph node (SN); hence, the aim of this study was to assess survival rates of these patients. For the purpose of this analysis, the patients with stage III melanoma were identified from the prospective melanoma database at the Institute of Oncology Ljubljana, Slovenia, which includes more than 1000 patients. Patients were divided into four groups: • delayed therapeutic lymph node dissection (TLND) • CLND after positive SLNB • synchronous primary melanoma and regional lymph node metastases • lymph node metastases for unknown primaries The worst 5-year overall survival (OS) had the patients with synchronous primary melanoma and regional lymph node metastases. The patients with SN metastases with a diameter of more than 5.0 mm had significantly worse OS than those with delayed TLND, while the patients with SLNB metastases with a diameter of 5.0 mm or less had significantly better OS than those with delayed TLND even after the patients with false positive SLNB (diameter less than 0.3 mm) were excluded. The group of patients with positive SLNB is contaminated with the false positive patients as well as with the patients with more aggressive disease. The majority of SN positive patients, however, have an OS benefit in comparison to the patients with delayed TLND.


Arhiv

niGradiv

Nazaj